DENTSPLY director granted 28,887 RSUs

MCKEON BRIAN P reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

MCKEON BRIAN P reported acquisition or exercise transactions in this Form 4 filing.

DENTSPLY SIRONA Inc. director Brian P. McKeon reported an equity compensation award on Form 4. He received 28,887 shares of Common Stock in the form of Restricted Stock Units that were granted at no cash cost and will vest in full one year from the grant date. Following this award, he directly holds 28,887 shares reported in this filing.

Insider Trade Summary

Grant/Award: 28,887 shares

Grant/Award 1 txn

Insider MCKEON BRIAN P

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	28,887	$0.00	$0.00

Holdings After Transaction: Common Stock — 28,887 shares (Direct)

Footnotes (1)

1. F1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

Key Figures

RSU grant size: 28,887 shares Grant price: $0.0000 per share Post-transaction holdings: 28,887 shares +2 more

5 metrics

RSU grant size 28,887 shares Restricted Stock Units awarded to director

Grant price $0.0000 per share Stated transaction price for RSU grant

Post-transaction holdings 28,887 shares Total Common Stock directly owned after award

Vesting period One year RSUs vest in full one year from grant date

Transaction code A Grant, award, or other acquisition

Key Terms

Restricted Stock Units (RSUs), Common Stock, Grant, award, or other acquisition, Form 4

4 terms

Restricted Stock Units (RSUs) financial

"This grant consists entirely of Restricted Stock Units (RSUs) that vest in full..."

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

Common Stock financial

"security_title: Common Stock reported as the underlying security in the transaction"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 regulatory

"INSIDER FILING DATA (Form 4): structured data for the insider transaction"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Brian P. McKeon report for DENTSPLY SIRONA (XRAY)?

Brian P. McKeon reported receiving an equity award of 28,887 shares of Common Stock. The award was granted as Restricted Stock Units at no cash cost and is recorded as a grant or other acquisition on his Form 4 filing.

How many DENTSPLY SIRONA (XRAY) shares did Brian P. McKeon acquire in this Form 4?

He acquired 28,887 shares of Common Stock through a grant. These shares are tied to Restricted Stock Units, meaning they are subject to vesting conditions before becoming fully unrestricted for him as the reporting director.

What are the vesting terms of Brian P. McKeon’s RSU grant at DENTSPLY SIRONA (XRAY)?

The grant consists entirely of Restricted Stock Units that vest in full one year from the date of grant. When the one-year period ends, the restrictions lapse and the underlying shares become fully vested for the reporting person.

What was the price per share for Brian P. McKeon’s DENTSPLY SIRONA (XRAY) grant?

The reported transaction price per share was $0.0000 for the 28,887-share grant. This reflects that the award was part of compensation and not an open-market purchase, so no cash payment per share was made by the director.

How many DENTSPLY SIRONA (XRAY) shares does Brian P. McKeon hold after this transaction?

After the grant of 28,887 Restricted Stock Units linked to Common Stock, the total number of shares reported as directly owned by Brian P. McKeon is 28,887. This figure reflects his position following the reported equity compensation award.

Is Brian P. McKeon’s DENTSPLY SIRONA (XRAY) transaction a market buy or compensation grant?

The transaction is a compensation grant, not a market buy. It is coded as a grant, award, or other acquisition, with 28,887 shares received at a stated price of $0.0000 per share, indicating a Restricted Stock Unit award to the director.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/05/2026 - 05:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCKEON BRIAN P

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NORTH CAROLINA 28277

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/03/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/03/2026		A		28,887(1)	A	$0	28,887	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.

	/s/ Jessica Nielsen Causey, Attorney-In-Fact for Brian P. McKeon	06/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)